74 related articles for article (PubMed ID: 1341123)
1. [Patients with panic disorder: a 5-year follow-up study].
León CA; Arévalo W; Gaviria LF; Leon A
Acta Psiquiatr Psicol Am Lat; 1992 Dec; 38(4):279-88. PubMed ID: 1341123
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
[TBL] [Abstract][Full Text] [Related]
3. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
Deltito JA; Argyle N; Klerman GL
J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
Pollack MH; Otto MW; Tesar GE; Cohen LS; Meltzer-Brody S; Rosenbaum JF
J Clin Psychopharmacol; 1993 Aug; 13(4):257-63. PubMed ID: 8376613
[TBL] [Abstract][Full Text] [Related]
5. Cognitive behavior therapy for treatment-refractory panic disorder.
Pollack MH; Otto MW; Kaspi SP; Hammerness PG; Rosenbaum JF
J Clin Psychiatry; 1994 May; 55(5):200-5. PubMed ID: 8071270
[TBL] [Abstract][Full Text] [Related]
6. Treatment of panic disorder.
Cassano GB; Toni C; Musetti L
Adv Biochem Psychopharmacol; 1992; 47():449-60. PubMed ID: 1509926
[No Abstract] [Full Text] [Related]
7. Diazepam versus alprazolam for the treatment of panic disorder.
Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
[TBL] [Abstract][Full Text] [Related]
8. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
[TBL] [Abstract][Full Text] [Related]
9. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Rickels K; Schweizer E; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.
Rimón R; Lepola U; Jolkkonen J; Halonen T; Riekkinen P
Biol Psychiatry; 1995 Dec; 38(11):737-41. PubMed ID: 8580226
[TBL] [Abstract][Full Text] [Related]
11. Effects of panic disorder treatments on personality disorder characteristics.
Hofmann SG; Shear MK; Barlow DH; Gorman JM; Hershberger D; Patterson M; Woods SW
Depress Anxiety; 1998; 8(1):14-20. PubMed ID: 9750974
[TBL] [Abstract][Full Text] [Related]
12. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
Weissman MM; Prusoff B; Sholomskas AJ; Greenwald S
J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
[TBL] [Abstract][Full Text] [Related]
13. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
Modigh K; Westberg P; Eriksson E
J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
[TBL] [Abstract][Full Text] [Related]
14. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
[TBL] [Abstract][Full Text] [Related]
15. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
16. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.
Br J Psychiatry; 1992 Feb; 160():191-202; discussion 202-5. PubMed ID: 1540759
[TBL] [Abstract][Full Text] [Related]
17. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Pollack MH; Otto MW; Sachs GS; Leon A; Shear MK; Deltito JA; Keller MB; Rosenbaum JF
J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
[TBL] [Abstract][Full Text] [Related]
18. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
Pols H; Verburg K; Hauzer R; Meijer J; Griez E
Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
[TBL] [Abstract][Full Text] [Related]
20. Panic disorder: treatment with valproate.
Woodman CL; Noyes R
J Clin Psychiatry; 1994 Apr; 55(4):134-6. PubMed ID: 8071256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]